{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:35:02Z","timestamp":1787016902018,"version":"build-2736575974"},"reference-count":42,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,11,11]]},"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>A previously healthy Japanese woman in her 20s was admitted to our hospital with a 2-week history of fever (39.0\u00b0C) and a 1-week history of painful cervical lymphadenopathy. The day before fever onset, she had received her first Pfizer-BioNTech SARS-CoV-2 vaccine in her left arm. She had previously been treated with empirical antibiotics with no improvement. Physical examination revealed painful lymphadenopathy in both posterior cervical regions. CT showed symmetrical lymphadenopathies in the neck, supraclavicular, axillary and inguinal regions as well as hepatosplenomegaly. We suspected lymphoma and performed a lymph node biopsy in the right inguinal region, which revealed necrotising histiocytic lymphadenitis. The patient was, therefore, diagnosed with Kikuchi-Fujimoto disease (KFD). She improved after the corticosteroid therapy. This report highlights the importance of including KFD as a differential diagnosis of lymphadenopathy after SARS-CoV-2 vaccination. Additionally, lymph node biopsy is helpful for diagnosing KFD because it rules out other entities.<\/jats:p>","DOI":"10.1136\/bcr-2022-250601","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T10:41:03Z","timestamp":1669113663000},"page":"e250601","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination"],"prefix":"10.1136","volume":"15","author":[{"given":"Kohsuke","family":"Ikeda","sequence":"first","affiliation":[{"name":"Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4556-8412","authenticated-orcid":false,"given":"Eiichi","family":"Kakehi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Adachi","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Tottori Municipal Hospital, Tottori, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kotani","sequence":"additional","affiliation":[{"name":"Division of Community and Family Medicine, Jichi Medical University, Shimotsuke, Tochigi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"2025082710141363000_15.11.e250601.1","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.5858\/arpa.2018-0219-RA","article-title":"Kikuchi-Fujimoto disease: a review","volume":"142","author":"Perry","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"2025082710141363000_15.11.e250601.2","first-page":"120","article-title":"Kikuchi-Fujimoto disease: a clinicopathologic update","volume":"108","author":"Pepe","year":"2016","journal-title":"Pathologica"},{"key":"2025082710141363000_15.11.e250601.3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4081\/reumatismo.2019.1130","article-title":"Kikuchi-Fujimoto disease with multiple extra-nodal features - A clinical mimic","volume":"71","author":"Mansoor","year":"2019","journal-title":"Reumatismo"},{"key":"2025082710141363000_15.11.e250601.4","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-021-01480-7"},{"key":"2025082710141363000_15.11.e250601.5","first-page":"1663","article-title":"COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer\/BioNTech and Moderna vaccines","volume":"25","author":"Meo","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025082710141363000_15.11.e250601.6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.crad.2021.04.010","article-title":"Unilateral axillary adenopathy following COVID-19 vaccination: a multimodality pictorial illustration and review of current guidelines","volume":"76","author":"Brown","year":"2021","journal-title":"Clin Radiol"},{"key":"2025082710141363000_15.11.e250601.7","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2021.e01253","article-title":"Kikuchi-Fujimoto disease following SARS CoV2 vaccination: case report","volume":"25","author":"Soub","year":"2021","journal-title":"IDCases"},{"key":"2025082710141363000_15.11.e250601.8","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines9111251","article-title":"Kikuchi-Fujimoto disease post COVID-19 vaccination: case report and review of literature","volume":"9","author":"Tan","year":"2021","journal-title":"Vaccines"},{"key":"2025082710141363000_15.11.e250601.9","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.3324\/haematol.2021.280239","article-title":"Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination","volume":"107","author":"Caocci","year":"2022","journal-title":"Haematologica"},{"key":"2025082710141363000_15.11.e250601.10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12308-021-00477-1","article-title":"Kikuchi-Fujimoto disease following vaccination against COVID-19","volume":"15","author":"Guan","year":"2022","journal-title":"J Hematop"},{"key":"2025082710141363000_15.11.e250601.11","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2022.2071080","article-title":"Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination","volume":"18","author":"Kashiwada","year":"2022","journal-title":"Hum Vaccin Immunother"},{"key":"2025082710141363000_15.11.e250601.12","article-title":"Kikuchi-Fujimoto's disease or histiocytic necrotizing lymphadenitis following mRNA COVID-19 vaccination: a rare case","volume":"14","author":"Daghri","year":"2022","journal-title":"Cureus"},{"key":"2025082710141363000_15.11.e250601.13","doi-asserted-by":"publisher","DOI":"10.1007\/s13167-017-0101-y"},{"key":"2025082710141363000_15.11.e250601.14","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.151"},{"key":"2025082710141363000_15.11.e250601.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2019.06.012"},{"key":"2025082710141363000_15.11.e250601.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjoms.2021.04.008"},{"key":"2025082710141363000_15.11.e250601.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-006-0230-5"},{"key":"2025082710141363000_15.11.e250601.18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/00000478-199009000-00009","article-title":"Cutaneous manifestation of Kikuchi's histiocytic necrotizing lymphadenitis","volume":"14","author":"Kuo","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"2025082710141363000_15.11.e250601.19","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/BF02899691","article-title":"Immunohistological study of skin involvement in Kikuchi's disease","volume":"62","author":"Sumiyoshi","year":"1992","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"2025082710141363000_15.11.e250601.20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/BF01600281","article-title":"A case of histiocytic necrotizing lymphadenitis with bone marrow and skin involvement","volume":"420","author":"Sumiyoshi","year":"1992","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"key":"2025082710141363000_15.11.e250601.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577"},{"key":"2025082710141363000_15.11.e250601.22","unstructured":"The Moderna COVID-19 Vaccine\u2019s Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events. Available: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/moderna\/reactogenicity.html [Accessed 3 Mar 2022]."},{"key":"2025082710141363000_15.11.e250601.23","unstructured":"Pfizer-BioNTech COVID-19 Vaccine Reactions & Adverse Events. Available: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/pfizer\/reactogenicity.html [Accessed 3 Mar 2022]."},{"key":"2025082710141363000_15.11.e250601.24","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2012.70"},{"key":"2025082710141363000_15.11.e250601.25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/cyt.12073","article-title":"Epstein-Barr virus encoded RNA detected by in situ hybridization using cytological preparations","volume":"25","author":"Garady","year":"2014","journal-title":"Cytopathology"},{"key":"2025082710141363000_15.11.e250601.26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5826\/dpc.0401a06","article-title":"Subacute cutaneous lupus erythematosus onset preceded by Kikuchi-Fujimoto disease","volume":"4","author":"Di Lernia","year":"2014","journal-title":"Dermatol Pract Concept"},{"key":"2025082710141363000_15.11.e250601.27","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.arcped.2017.02.027","article-title":"[Kikuchi-Fujimoto disease mimicking malignant lymphoma in adolescents]","volume":"24","author":"Escudier","year":"2017","journal-title":"Arch Pediatr"},{"key":"2025082710141363000_15.11.e250601.28","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00004728-199301000-00024","article-title":"Cervical lymphadenopathy due to Kikuchi disease: US and CT appearance","volume":"17","author":"Fulcher","year":"1993","journal-title":"J Comput Assist Tomogr"},{"key":"2025082710141363000_15.11.e250601.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)61767-1"},{"key":"2025082710141363000_15.11.e250601.30","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0782-6"},{"key":"2025082710141363000_15.11.e250601.31","doi-asserted-by":"publisher","DOI":"10.1258\/0022215001906561"},{"key":"2025082710141363000_15.11.e250601.32","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(196804)21:4<632::AID-CNCR2820210415>3.0.CO;2-O"},{"key":"2025082710141363000_15.11.e250601.33","first-page":"1669","article-title":"Illness after measles-mumps-rubella vaccination","volume":"149","author":"Freeman","year":"1993","journal-title":"CMAJ"},{"key":"2025082710141363000_15.11.e250601.34","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jfma.2018.09.012","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination-associated axillary lymphadenopathy in\u00a0a\u00a02-year-old girl: Case report","volume":"118","author":"Wang","year":"2019","journal-title":"J Formos Med Assoc"},{"key":"2025082710141363000_15.11.e250601.35","first-page":"188","article-title":"Cutaneous lymphoid hyperplasia and reactive lymphadenopathy induced by hepatitis B vaccination","volume":"18","author":"Atalar","year":"2008","journal-title":"Eur J Dermatol"},{"key":"2025082710141363000_15.11.e250601.36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.28.9.1194","article-title":"Development of unilateral cervical and supraclavicular lymphadenopathy after human papilloma virus vaccination","volume":"28","author":"Studdiford","year":"2008","journal-title":"Pharmacotherapy"},{"key":"2025082710141363000_15.11.e250601.37","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231582","article-title":"Neck and supraclavicular lymphadenopathy secondary to 9-valent human papillomavirus vaccination","volume":"12","author":"Pereira","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2025082710141363000_15.11.e250601.38","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/459543","article-title":"Lymphadenitis as a rare side effect of H1N1 vaccine in a child","volume":"2010","author":"Gundogdu","year":"2010","journal-title":"Case Rep Med"},{"key":"2025082710141363000_15.11.e250601.39","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e318273de7f"},{"key":"2025082710141363000_15.11.e250601.40","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/fon.12.37","article-title":"Tetanus toxoid reactive lymphadenopathy masquerading as T-cell lymphoma","volume":"8","author":"White","year":"2012","journal-title":"Future Oncol"},{"key":"2025082710141363000_15.11.e250601.41","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2003.18.3.459"},{"key":"2025082710141363000_15.11.e250601.42","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00431-012-1729-1","article-title":"Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis","volume":"171","author":"Watanabe","year":"2012","journal-title":"Eur J Pediatr"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-250601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T17:14:21Z","timestamp":1756314861000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-250601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":42,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2022,11,22]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bcr-2022-250601"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-250601","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}